ixazomib and Smoldering-Multiple-Myeloma

ixazomib has been researched along with Smoldering-Multiple-Myeloma* in 2 studies

2 other study(ies) available for ixazomib and Smoldering-Multiple-Myeloma

Article	Year
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study. Leukemia & lymphoma, 2022, Volume: 63, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Boron Compounds; Dexamethasone; Humans; Multiple Myeloma; Pilot Projects; Smoldering Multiple Myeloma	2022
Ixazomib as treatment for pyoderma gangrenosum associated with IgA smoldering multiple myeloma. Annals of hematology, 2022, Volume: 101, Issue:2 Topics: Aged; Antineoplastic Agents; Boron Compounds; Glycine; Humans; Immunoglobulin A; Male; Pyoderma Gangrenosum; Smoldering Multiple Myeloma	2022